Closing prices at the end of each trading day, from 5 Feb 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 19.3 | 21.9 | 9.7 | 10.4 |
| Growth | +13.8% | −55.6% | +7.1% | |
| Operating income | −1.0 | −7.3 | −7.2 | −33.3 |
| Net income | −0.9 | −6.0 | −5.5 | −39.4 |
| Growth | ||||
| EPS, diluted | −0.08 | −0.50 | −0.46 | −2.71 |
| Growth |
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Operating margin | −5.4% | −33.2% | −74.2% | −319.1% |
| Net margin | −4.9% | −27.4% | −56.7% | −377.0% |
| Free cash flow margin | n/a | 46.4% | −96.3% | −768.1% |
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Operating cash flow | 36.0 | 10.2 | −8.1 | −80.1 |
| Capital expenditure | n/a | −0.0 | −1.3 | −0.0 |
| Free cash flow | n/a | 10.2 | −9.4 | −80.2 |
| Growth | −192.2% |
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash | 12.7 | 12.0 | 30.6 | 13.0 |
| Shareholders’ equity | 80.1 | 60.7 | 55.2 | 87.0 |
In millions of HKD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.
| Fiscal year | FY2022 31 Dec 2022 | FY2023 31 Dec 2023 | FY2024 31 Dec 2024 | FY2025 31 Dec 2025 |
|---|---|---|---|---|
| Assets | ||||
| 12.7 | 12.0 | 30.6 | 13.0 | |
| n/a | 0.0 | 1.0 | 0.6 | |
| 123.4 | 106.6 | 71.7 | 119.3 | |
| Growth | −13.6% | −32.7% | +66.3% | |
| Liabilities | ||||
| 43.3 | 45.9 | 16.5 | 32.2 | |
| Equity | ||||
| n/a | −2.4 | −7.9 | −47.3 | |
| 80.1 | 60.7 | 55.2 | 87.0 | |
| Growth | −24.1% | −9.1% | +57.6% | |
| Per share and net cash | ||||
| n/a | 12.0 | 12.0 | 15.4 | |
| calc | n/a | 5.06 | 4.60 | 5.67 |
Lines marked calc are worked out here from filed figures; point at one for how. Shown in HKD as filed; the screener converts to dollars.